EXAGEN INC. Total Liabilities
EXAGEN INC. (XGN) had Total Liabilities of $39.72 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-04
- 2026-06-30: Liabilities $39.72M.
- 2026-03-31: Liabilities $37.52M.
- 2025-12-31: Liabilities $40.57M.
- 2025-09-30: Liabilities $44.69M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $39.72M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $37.52M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $40.57M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $44.69M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $37.73M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $33.89M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $35.15M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $30.74M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $31.72M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $30.82M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $34.25M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $33.42M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $32.28M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $43.30M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $43.76M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $45.41M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $44.02M 10-Q/A · filed 2022-11-21 | $43.54M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $45.89M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $38.51M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $36.97M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $36.94M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $36.05M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $36.54M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $35.52M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $32.67M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $34.11M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $32.65M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $34.09M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $35.62M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |